Expand your deal flow with tailored startup sourcing,
investment intelligence, and continuous monitoring.
DealBio helps investors source health and longevity startups, follow their progress, and learn from acquisitions and IPOs.
Investor-focused research on health and longevity startups, covering what they are building, who is behind them, and how far they have progressed.
Ongoing updates showing which startups are gaining momentum.
Bioprinting startup receives €36,000 through Bavaria's Start?Zuschuss! programme.
Building sensor-equipped bioprinters for human tissue models and drug research.
Child-development app Tweexy reaches 350+ families in 20+ countries, with 30+ paying users and a 9.6% organic conversion rate.
Providing game-based screening for ADHD and related conditions.
Mental-health AI startup launches a Municipal Emotional Wellbeing Observatory with Eibar City Council, reaching residents through its Bruna assistant.
Building AI clinical decision support for mental-health professionals.
Heart-monitoring startup receives early-phase VFF loan from ROM Utrecht Region to develop RF-sensing technology for earlier heart-failure detection.
Developing a wearable radio-frequency sensor for home heart-function monitoring.
Obesity-research startup wins Venture Kick Stage 1 support to strengthen market access with industry and research partners.
Building 3D human fat-tissue models for obesity drug development.
Cardiac AI startup named a finalist for the Emerging Life Sciences Star Award at the UK tech awards 2026.
Developing AI-ECG software that detects hidden cardiac disease signals from routine ECGs.
Brain-surgery imaging startup secures its first two granted US patents, covering a minimally invasive optical forward-viewing probe and an automated drilling device.
Developing real-time OCT imaging with AI navigation for brain surgery.
Laura Fletcher, Director of Strategic Partnerships at Bind Research, rejoins the board as independent non-executive director and corporate development advisor.
Developing in vivo mRNA-LNP therapeutics that reprogram pathogenic T cells for autoimmune disease.
Protein-prediction startup leads a team selected for SPRIND's QuantumSense Exploration challenge.
Using AI to predict protein expression, stability and developability before lab work.
Swiss biotech entrepreneur Roger Meier, co-founder of Cellestia Biotech and T3 Pharmaceuticals, joins the board initially as an observer.
Developing nucleotide-based products for cellular resilience and healthy aging.
Sobriety platform expands its clinic from one state to five in 30 days, now prescribing medication in Pennsylvania, Michigan, Florida, Georgia and Utah.
Building a sobriety platform combining peer support, AI, and therapy.
Ageing geneticist João Pedro de Magalhães, Professor of Molecular Biogerontology at the University of Birmingham, joins as Strategic Scientific Advisor.
Developing nucleotide-based products for cellular resilience and healthy aging.
Insomnia study's 3-month follow-up shows ISI scores down 9.4 points from baseline, with 87% of 61 patients no longer at moderate or severe insomnia.
Building Noxxea, a digital medicine for chronic insomnia.
Brain-computer interface startup wins the Responsible AI Start-up Contest in Rotterdam, selected from 17 entries and six finalists.
Turning brain signals into speech and device control for people with paralysis.
Health testing marketplace launches $249 coronary artery calcium scans, orderable without a referral at more than 1,000 US imaging centers.
Offering at-cost biomarker testing with AI-guided preventive health insights.
A selection of health and longevity startups, researched for investors.
Explore acquisitions and IPOs across health and longevity, including transaction values, acquirers, and time to exit.
Developed rapid blood tests that detected sepsis-causing bacteria and fungi directly from whole blood.
Developed HIV drugs and resistance tests that helped doctors choose treatments more likely to work.
Built connected scales, watches, and health monitors that automatically turned everyday measurements into usable health insights.
Combined connected devices, personalized guidance, and coaching to help people manage diabetes and other chronic conditions.
Offered at-home hormone tests that helped women understand fertility, ovarian reserve, and reproductive planning.
Developed fish-skin grafts that help the body repair chronic, diabetic, burn, surgical, and trauma wounds.
Provided direct-to-consumer delivery of catheters and ostomy supplies across the United States.
Developed minimally invasive surgical products for female stress urinary incontinence and pelvic organ prolapse.
Developed compact PCR tests that delivered rapid molecular results near patients with infectious diseases.
Developed genomic tests that assessed prostate cancer risk and helped clinicians guide treatment decisions.
Developed blood and tissue genomic tests that profiled cancers and helped guide targeted treatments.
Developed collagen implants that supported tendon and ligament healing after orthopedic and sports injuries.
Offered virtual primary and urgent care for diagnosis, prescriptions, and ongoing treatment from home.
Developed connected inhaler sensors and software that helped manage asthma and chronic lung disease.
Built a food and exercise tracking app that helped users monitor calories, nutrition, weight, and activity.
Offered virtual weight-management care combining clinician visits, medication access, and ongoing coaching.
Developed vitamins, minerals, and supplements sold through healthcare practitioners and consumer channels.
Developed robotic systems that helped physicians diagnose and treat disease through minimally invasive procedures.
Developed real-time ultrasound systems that helped surgeons visualize anatomy and guide decisions during operations.
Developed wearable cardiac monitors and remote services that detected irregular heart rhythms outside hospitals.
Developed automated pharmacy systems that helped hospitals store, package, track, and dispense medications safely.
Developed a non-hormonal therapy designed to reduce hot flashes and other symptoms of menopause.
Developed small-molecule therapies targeting neurokinin pathways to treat menopause and hormone-related conditions.
Offered microbiome sequencing and analysis services that helped researchers measure microbial communities.
Offered inpatient and outpatient treatment for addiction and behavioral health conditions across care centers.
Built oncology software and real-world data tools that supported cancer care and treatment research.
Developed blood-based genomic tests designed to detect multiple cancers before symptoms appeared.
Offered clinical genetic tests that identified inherited disease risks and guided personalized care decisions.
Developed genomic testing tools that helped laboratories detect cancer mutations and guide targeted treatments.
Developed gene therapies for retinal diseases by targeting biological pathways involved in vision loss.
Developed stem-cell gene therapies designed to give people with HIV long-lasting resistance to the virus.
Developed antiviral medicines for respiratory syncytial virus in infants and other vulnerable patients.
Developed antiviral medicines for respiratory syncytial virus and other infections affecting infants and adults.
Developed AI software that analyzed medical images to help clinicians detect and prioritize suspected conditions.
Developed a non-steroidal topical medicine for treating plaque psoriasis and atopic dermatitis.
Developed capsules, formulation technologies, and manufacturing services used to produce and deliver medicines.
Developed injectable medicines targeting metabolic diseases, including obesity and diabetes.
Developed reproductive genetic tests that helped IVF clinics assess embryos, fertility risks, and pregnancy outcomes.
Offered donor reproductive tissue, fertility preservation, and newborn stem-cell storage for families and clinics.
Developed a connected home-fitness mirror that delivered live and on-demand exercise classes.
Developed mobile fitness-tracking and training apps connected to smartphones and wearable devices.
Built a mobile training app that tracked workouts and provided social and coaching features for active users.
Developed genomic tumor profiling tests that helped clinicians select targeted cancer treatments and trials.
Developed implantable nerve-stimulation systems that helped treat bladder and bowel control disorders.
Developed spinal cord stimulation systems that used electrical pulses to help patients manage chronic pain.
Developed spinal implants and surgical tools that helped clinicians treat complex spine disorders.
Built a healthcare navigation platform that helped employees understand benefits and access appropriate care.
Offered primary care for older adults, coordinating preventive, chronic, and social support services.
Developed antibody-drug conjugates that delivered cancer medicines more directly to tumor cells.
Developed targeted cancer medicines matched to tumor mutations rather than the cancer's organ of origin.
Developed robotic systems that helped surgeons plan and perform knee and hip replacement procedures.
Developed software that helped hospitals and radiologists store, manage, and analyze medical images.
Developed medicines that helped treat schizophrenia, bipolar depression, and other brain disorders.
Developed muscarinic receptor medicines to treat schizophrenia and other neurological conditions.
Developed medicines for postpartum depression and other brain conditions involving disrupted signaling.
Developed gene replacement therapy that addressed the underlying cause of spinal muscular atrophy.
Developed CAR-T therapies that reprogrammed patients' immune cells to recognize and attack cancer.
Developed CAR-T therapies that used patients' engineered immune cells to treat blood cancers.
Developed targeted medicines for autoimmune and inflammatory diseases caused by abnormal immune responses.
Offered clinical research services that helped drug developers plan and run clinical trials.
Developed wearable devices and software that tracked activity, sleep, heart rate, and health trends.
Developed cancer medicines that used antibodies to carry protein-degrading drugs directly into tumor cells.
Developed long-acting antibody medicines designed to relieve chronic itch and inflammatory skin disease.
Developed an oral medicine that blocked a tumor-growth protein to treat kidney cancer.
Developed small molecules designed to reverse the immune suppression that protects tumors.
Developed cartridge-based PCR systems that delivered rapid molecular test results near patients.
Developed gene therapies delivered into the brain for Parkinson's disease and other neurodegenerative conditions.
Developed robotic guidance systems that helped surgeons place implants during spine operations.
Developed gene expression tests that predicted cancer recurrence and guided chemotherapy decisions.
Offered membership-based primary care combining in-office visits, on-site labs and virtual care.
Sold at-home biomarker tests alongside supplements, using results to personalize recommendations.
Managed fertility and family-building benefits sold to self-insured employers.
Developed small-molecule medicines designed to calm the immune system in inflammatory conditions.
Developed an oral medicine designed to work alongside standard treatment for a rare bone-marrow cancer.
Developed an antibody treatment for a virus that attacks the kidney in transplant patients.
Developed antiviral medicines for HIV and hepatitis, including nucleoside-based treatment candidates.
Developed PET imaging agents designed to detect amyloid plaques associated with Alzheimer's disease.
Developed antibodies and biomarker tools used in tests for Alzheimer's and other neurodegenerative diseases.
Developed high-throughput proteomics technology that measured thousands of proteins from small samples.
Developed magnetic breast-surgery tools that helped locate tumors and map lymph nodes without radiation.
Developed breast-cancer surgery and radiation devices for tumor localization and targeted treatment.
Developed fluorescence imaging systems that helped surgeons visualize blood flow and tissue perfusion.
Developed MRI-guided laser systems for minimally invasive ablation of abnormal brain tissue.
Developed intravascular imaging and pressure-measurement tools used to guide coronary procedures.
Developed defibrillators, cardiac monitors, and resuscitation technologies for emergency and hospital care.
Developed defibrillators, cardiac monitors, and CPR devices for emergency medical response.
Developed NARCAN nasal spray to reverse opioid overdoses without requiring an injection.
Developed stem-cell-derived pancreatic islet cells intended to restore insulin production in diabetes.
Developed engineered cell therapies using induced pluripotent stem cells for neurological and cardiac disease.
Developed RNA-based medicines designed to treat heart disease by targeting non-coding RNA pathways.
Developed engineered antibody therapies designed to target difficult proteins in infectious and kidney diseases.
Developed antibiotics for serious bacterial infections, including therapies for drug-resistant pathogens.
Provided remote radiology reporting services that connected hospitals with specialist radiologists.
Developed sleep-apnea and respiratory devices, including CPAP systems and home ventilation equipment.
Developed an antibody that blocked immune signaling driving vitiligo, celiac disease, and other autoimmune conditions.
Manufactured plasmid DNA, mRNA and proteins used in gene therapies, vaccines and gene-editing research.
Manufactured viral vectors used to develop and produce gene and cell therapies for clinical programs.
Developed microRNA-targeting medicines designed to regulate disease-driving genetic pathways.
Developed RNA interference medicines designed to silence disease-causing genes in the liver and other tissues.
Developed Dermagraft, a living-cell skin substitute used to treat chronic diabetic foot ulcers.
Developed implantable neurostimulation systems used to manage chronic pain and neurological conditions.
Developed devices that helped physicians access and navigate the heart during catheter-based procedures.
Developed vascular closure systems that sealed access sites after catheter-based cardiovascular procedures.
Developed radioactive microspheres delivered through arteries to treat liver tumors from inside the body.
Developed minimally invasive vascular devices used in catheterization and interventional procedures.
Developed an immunotherapy designed to activate innate immune responses against solid tumors.
Developed a wearable ECG patch that recorded cardiac rhythms to help detect arrhythmias.
Engineered enzymes and proteins for pharmaceutical manufacturing, drug discovery and other industrial uses.
Built an AI-enabled platform combining protein design and wet-lab screening to develop biologic medicines.
Developed protein-biomarker tests that assessed the risk of acute kidney injury in hospitalized patients.
Developed urine and blood tests that analyzed exosomal RNA to detect and monitor cancer.
Provided digital mental-health programs combining therapeutic content, coaching and peer support.
Provided digital mental-health programs delivering structured behavioral therapy through online care.
Developed transdermal drug-delivery systems and patches for prescription and consumer medicines.
Developed an oral medicine designed to slow vision loss in an inherited eye disease that begins in childhood.
Developed immune-modulating biologic therapies for cancer, autoimmune disease, and severe COVID-19.
Built fitness-tracking apps that let users record, map, and analyze running, cycling, and other workouts.
Provided outpatient mental healthcare through clinics and telehealth for therapy and psychiatric care.
Developed molecular profiling and AI tools that helped guide personalized cancer treatment decisions.
Developed oncolytic virus therapies designed to infect and destroy tumor cells while stimulating immunity.
Developed oncolytic virus immunotherapies designed to infect and kill cancer cells and stimulate immunity.
Developed oncolytic virus therapies designed to trigger immune responses against solid tumors.
Developed antibody-oligonucleotide conjugates designed to deliver RNA medicines directly to muscle tissue.
Combined family-history records and consumer DNA testing to help people explore ancestry and genetic traits.
Provided digital musculoskeletal care using exercise therapy, sensors, and remote clinical support.
Manufactured human milk oligosaccharides used to add breast-milk-like components to infant nutrition.
Produced human milk oligosaccharides by fermentation for use in infant nutrition and health products.
Developed infant formula and pediatric nutrition products, including the Enfamil and Nutramigen brands.
Developed gene therapies and AAV vector technology for rare neuromuscular and neurological diseases.
Developed home sleep-apnea diagnostic devices that connected sleep testing with cardiovascular care.
Developed ROSA robotic systems that assisted surgeons with brain and spine procedures.
Developed stent grafts and vascular surgical products used to repair diseases of the aorta.
Offered virtual digestive care combining dietitian-led programmes and clinician support through employer health plans.
Developed an oral medicine for a rare inherited disease that leaves bones soft and easily broken.
Developed a wrist-worn neural interface that translated nerve and muscle signals into computer controls.
Developed efruxifermin, an FGF21 therapy for metabolic dysfunction-associated steatohepatitis.
Developed pegozafermin, an FGF21 therapy for metabolic liver disease and severe hypertriglyceridemia.
Developed a blood-brain barrier delivery platform and an antibody therapy for Alzheimer’s disease.
Developed clinically backed probiotic products and microbiome-based products for human gut health.
Developed and manufactured clinically documented probiotic strains, blends and dietary supplements.
Developed Nanobody therapeutics, single-domain antibody medicines for rare and immune-mediated diseases.
Developed multispecific antibody therapies for cancer, including late-stage EGFR-targeted treatments.
Developed antibody-drug conjugation technology for attaching drug payloads to tumor-targeting antibodies.
Developed camera-based strength-training technology that tracked athlete performance in real time.
Built employee well-being software for health programs, engagement and organizational listening.
Built a corporate fitness and wellness platform giving employees access to physical and digital activities.
Developed ophthalmic surgical devices and systems for retinal, cataract and other eye procedures.
Developed autoinjector and drug-delivery devices alongside specialty pharmaceutical products.
Developed CAR-T cell therapies designed to reset the immune system in autoimmune diseases.
Developed engineered T-cell therapies designed to selectively eliminate disease-causing B cells.
Developed SIRP-targeted antibody medicines for immune-mediated diseases and cancer.
Provided healthcare IT consulting, managed services and workforce support for hospital clinical and business systems.
Manufactured fermentation-derived pharmaceutical APIs and intermediates for global drug companies.
Developed next-generation siRNA medicines for complement-mediated, rare and other diseases.
Manufactured active pharmaceutical ingredients and complex intermediates for generic and innovator drug companies.
Developed oral medicines designed to control seizures in a rare childhood epilepsy caused by a single gene fault.
Developed CD47-blocking cancer immunotherapies designed to activate macrophages against tumors.
Developed and manufactured human cell-based 3D tissue models and primary cells used for in vitro testing as alternatives to animal studies.
Built AI-powered software that helped clinical laboratories interpret genomic sequencing data.
Built software for genomic analysis and clinical interpretation, including inherited-disease and rapid-diagnosis workflows.
Developed topical medicines to prevent oral mucositis in patients receiving cancer treatment.
Developed precision liquid-dispensing instruments for life-science research, diagnostics and high-throughput production.
Developed antibody-drug conjugates for cancer, including the ovarian-cancer therapy ELAHERE.
Developed precision medicines for kidney diseases, including late-stage treatments for IgA nephropathy.
Developed biometric sensors and sleep-monitoring technology embedded in beds.
Developed AI software for digital pathology to support cancer diagnosis, biomarker discovery and research.
Developed AI-assisted obstetric ultrasound reporting and image-quality software for prenatal care.
Provided app-based digital therapy for musculoskeletal and pulmonary conditions using exercise, coaching and computer vision.
Developed targeted lipid nanoparticles that delivered RNA to engineer immune cells inside the body.
Developed continuous urine-output monitoring systems for hospital patients.
Developed point-of-care systems that concentrated platelets and bone-marrow cells for regenerative procedures.
Developed medicines for chronic skin diseases, including atopic dermatitis and excessive sweating.
Developed video-game-based digital treatments for attention and cognitive conditions, including ADHD.
Developed bacterial conjugate vaccines using a biological glycoengineering platform.
Developed multivalent bacterial vaccines using its Multiple Antigen Presenting System platform.
Developed advanced wound-care systems and dressings, including negative-pressure wound therapy.
Developed blood-based genomic tests for cancer detection, profiling and treatment selection.
Provided gut-microbiome testing and analytics while developing microbiome-derived therapeutics.
Developed medicines for chronic liver diseases, including seladelpar for primary biliary cholangitis.
Developed ultra-widefield retinal imaging systems for eye screening and clinical assessment.
Developed AI software that analyzed coronary CT scans to diagnose and manage coronary artery disease.
Developed rapid phenotypic antimicrobial-susceptibility testing directly from positive blood cultures.
Developed multiplex PCR systems that rapidly identified infectious organisms from patient samples.
Developed oral-fluid sample collection and stabilization products for molecular and genomic testing.
Developed women's-health diagnostic and medical products, including cervical-screening technology.
Developed therapies designed to restore frataxin and treat rare neurological diseases including Friedreich ataxia.
Built hardware and software that let clinicians record, edit, archive and review medical images during procedures, with a system widely used in ENT care.
Developed a urine test that tracked bladder cancer DNA to monitor patients after treatment.
Developed wearable biosensor patches that monitored heart rhythm and up to 11 vital signs for up to 30 days, in hospital and at home.
Developed medicines that act on the immune system's regulatory cells inside tissues to treat autoimmune and inflammatory diseases.
Developed biopreservation media and cell-processing tools used in cell and gene therapy manufacturing workflows.
